Relative Bioavailability of Three Different BI 456906 Formulations Following Subcutaneous Administration in Healthy Male and Female Subjects (an Open-label, Randomised, Single-dose, Three-period, Three-sequence Crossover Trial)
Latest Information Update: 21 Jan 2025
Price :
$35 *
At a glance
- Drugs Survodutide (Primary)
- Indications Liver cirrhosis; Non-alcoholic steatohepatitis; Obesity; Type 2 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Boehringer Ingelheim
- 21 Jan 2025 New trial record